Lv1
80 积分 2025-01-08 加入
Pegmolesatide ameliorates indoxyl sulfate-induced cardiomyocyte hypertrophy through modulating the EPOR-CD131-dependent JAK2/STAT3 signaling pathway
3个月前
已完结
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis
3个月前
已完结
Subcutaneous C.E.R.A. for the Maintenance Treatment of Anemia in Pediatric Patients With CKD: A Phase 2, Open-Label, Single-Arm, Multicenter Study
3个月前
已完结
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Anemia in CKD
7个月前
已完结
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary
9个月前
已完结
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
9个月前
已完结
Identification of erythropoietin mimetic peptide 1 linear form in a sealed vial and its administration study in horses for doping control purpose
9个月前
已完结
Method Development of Pegmolesatide for Doping Analysis: A Novel Synthetic Erythropoietin-Mimetic Agent
9个月前
已关闭
The transcriptional and regulatory identity of erythropoietin producing cells
9个月前
已完结
Polycystic kidney disease
10个月前
已完结
皖公网安备34019202002308
